Antibodies to Oxidized LDL and LDL-Containing Immune Complexes as Risk Factors for Coronary Artery Disease in Diabetes Mellitus

Low density lipoprotein undergoes oxidative modification in vivo.

Wulf Palinski, Michael E. Rosenfeld, Seppo Ylä‐Herttuala et al. · Proceedings of the National Academy of Sciences · 1989 · 1.5K citations · Full text

Life Sciences, Biochemistry, Pathobiology +17

Autoantibody against oxidised LDL and progression of carotid atherosclerosis

J T Salonen, H Korpela, R. Salonen et al. · The Lancet · 1992 · 1.3K citations · Full text

Life Sciences, Biochemistry, Molecular Medicine +11

Oxidatively modified low density lipoproteins: a potential role in recruitment and retention of monocyte/macrophages during atherogenesis.

Mark T. Quinn, Srinivasan Parthasarathy, Loren G. Fong et al. · Proceedings of the National Academy of Sciences · 1987 · 1.1K citations · Full text

Life Sciences, Biochemistry, Physiology +17

Minimally modified low density lipoprotein stimulates monocyte endothelial interactions.

J A Berliner, Mary Territo, Alex Sevanian et al. · Journal of Clinical Investigation · 1990 · 930 citations · Full text

Life Sciences, Biochemistry, Immunology +15

Pathogenic effects of advanced glycosylation: biochemical, biologic, and clinical implications for diabetes and aging.

Helen Vlassara, Richard Bucala, Liliane J. Striker · PubMed · 1994 · 853 citations

Life Sciences, Biochemistry, Endocrinology +16